Cargando…

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19

OBJECTIVES: This study aimed to estimate the cost-effectiveness of remdesivir, the first novel therapeutic to receive Emergency Use Authorization for the treatment of hospitalized patients with COVID-19, and identify key drivers of value to guide future pricing and reimbursement efforts. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whittington, Melanie D., Pearson, Steven D., Rind, David M., Campbell, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. 2022
Materias:	Themed Section: COVID-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856900/ https://www.ncbi.nlm.nih.gov/pubmed/35190252 http://dx.doi.org/10.1016/j.jval.2021.11.1378

Ejemplares similares

A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
por: Rafia, Rachid, et al.
Publicado: (2022)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
por: Vandepitte, Sophie, et al.
Publicado: (2021)

Cost Utility of Vaccination Against COVID-19 in Brazil
por: Fernandes, Ricardo Ribeiro Alves, et al.
Publicado: (2022)

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
por: Zhao, Jidi, et al.
Publicado: (2021)

Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
por: Ma, Siyu, et al.
Publicado: (2020)

“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs
por: Cheung, Douglas C., et al.
Publicado: (2022)

Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic
por: Kapinos, Kandice A., et al.
Publicado: (2022)

Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
por: Zala, Darshan, et al.
Publicado: (2020)

Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations
por: Dawoud, Dalia M., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan
por: Morales-Zamora, Gilberto, et al.
Publicado: (2022)

How Expensive Are Hospitalizations by COVID-19? Evidence From Colombia
por: Alvis-Zakzuk, Nelson J., et al.
Publicado: (2022)

Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals
por: Moon, Rena C., et al.
Publicado: (2022)

A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
por: Podolsky, Meghan I., et al.
Publicado: (2022)

Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
por: Caro, J. Jaime, et al.
Publicado: (2021)

Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic
por: Murteira, Rodrigo, et al.
Publicado: (2022)

Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
por: Shlomai, Amir, et al.
Publicado: (2021)

Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations
por: Elvidge, Jamie, et al.
Publicado: (2022)

Stewardship of Remdesivir Use in a Rural Community Hospital During the COVID-19 Pandemic
por: Tirupathi, Raghavendra, et al.
Publicado: (2021)

Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study
por: Chen, Zhenyuan, et al.
Publicado: (2022)

Americans’ Health Priorities During the COVID-19 Pandemic
por: Cook, Joseph, et al.
Publicado: (2022)

Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands
por: Mouter, Niek, et al.
Publicado: (2021)

Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries
por: Sun, Jichao, et al.
Publicado: (2022)

Facing the Threat of COVID-19 in Pakistan: A Nation’s Dilemma
por: Habib, Murad, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
por: Towse, Adrian, et al.
Publicado: (2021)

Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic
por: Lapin, Brittany R., et al.
Publicado: (2021)

Family Caregivers’ Experiences and Changes in Caregiving Tasks During the COVID-19 Pandemic
por: Irani, Elliane, et al.
Publicado: (2021)

Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
por: Dijk, Stijntje W., et al.
Publicado: (2022)

The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
por: Mullins, C. Daniel, et al.
Publicado: (2020)

Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England
por: Howlett, Nicholas C., et al.
Publicado: (2022)

Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
por: Patel, Dimple, et al.
Publicado: (2023)

Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs
por: Manski, Charles F., et al.
Publicado: (2021)

Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios
por: Vásquez, William F., et al.
Publicado: (2021)

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands
por: Wouterse, Bram, et al.
Publicado: (2022)

Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
por: Dal-Ré, Rafael, et al.
Publicado: (2022)

Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States
por: Basu, Anirban, et al.
Publicado: (2021)

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
por: Lau, Oscar, et al.
Publicado: (2022)

Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands
por: Mouter, Niek, et al.
Publicado: (2022)

Determinants of Face Mask Utilization to Prevent Covid-19 Pandemic among Quarantined Adults in Tigrai Region, Northern Ethiopia, 2020
por: Haftom, Mekonnen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5rtprb54q6mivptgn0n9mjbfe